Drug
Amg531
Amg531: highest development phase Phase 2, developed by Kyowa Kirin. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Kyowa Kirin
Trials
| Drug | Phase | Indication |
|---|---|---|
| AMG531 NCT02094417 | Phase 2 | Aplastic Anemia |
Latest
No recent events.
Follow Amg531 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.